Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-25-019295

Head of Global Product Strat. sold 2,223 shares at $135.00 ($300,105)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Izzar Rachid Head of Global Product Strat. 2025-07-08 Sale 10b5-1 −2,223 $135.00 $300,105 6,330 D
Open-market sales · 2,223 sh · avg $135.00 · $300,105
Loading xslF345X05/form4.xml…